A T Abreu Y Abreu, J A Velarde-Ruiz Velasco, M R Zavala-Solares, J M Remes-Troche, R I Carmona-Sánchez, J M Aldana-Ledesma, A Camacho-Ortiz, R Contreras-Omaña, R Díaz-Seoane, C T Elizondo-Vázquez, E Garza-González, G Grajales-Figueroa, O Gómez-Escudero, J S Jacobo-Karam, M Morales-Arámbula, L O Olivares-Guzmán, J Sifuentes-Osornio, A G Siu-Moguel, R Soto-Solís, L R Valdovinos-García, M A Valdovinos-Díaz, G Vázquez-Elizondo, S A Lazo-de la Vega Jasso
Journal: Revista de gastroenterologia de Mexico (English) 2019;84(2):204-219
PMID: 30987771
In recent decades, Clostridium difficile infection (CDI) has become a worldwide health problem. Mexico is no exception, and therefore the Asociación Mexicana de Gastroenterología brought together a multidisciplinary group (gastroenterologists, endoscopists, internists, infectious disease specialists, and microbiologists) to carry out the "Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection", establishing useful recommendations (in relation to the adult population) for the medical community. Said recommendations are presented herein. Among them, it was recognized that CDI should be suspected in subjects with diarrhea that have a history of antibiotic and/or immunosuppressant use, but that it can also be a community-acquired infection. A 2-step diagnostic algorithm was proposed, in which a highly sensitive test, such as glutamate dehydrogenase (GDH), is first utilized, and if positive, confirmed by the detection of toxins through immunoassay or nucleic acid detection tests. Another recommendation was that CDI based on clinical evaluation be categorized as mild-moderate, severe, and complicated severe, given that such a classification enables better therapeutic decisions to be made. In mild-moderate CDI, oral vancomycin is the medication of choice, and metronidazole is recommended as an alternative treatment. In addition, fecal microbiota transplantation was recognized as an efficacious option in patients with recurrence or in the more severe cases of infection, and surgery should be reserved for patients with severe colitis (toxic megacolon), in whom all medical treatment has failed.
Copyright © 2019 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.